Search clinical trials for: EE20/DRSP(BAY86-5300)

Total 43 results

Bayer

Completed

YAZ Post-marketing Surveillance in Japan

Dysmenorrhea

Japan
Bayer

Completed

Regulatory Post Marketing Surveillance Study on YAZ

Contraception | Acne | Premenstrual Syndrome

Korea, Republic of
Bayer

Completed

Comparative Study of BAY86-5300 With a Flexible Extended Regimen for Dysmenorrhea

Dysmenorrhea

Japan
Bayer

Completed

Study on Safety and Efficacy of an Oral Contraceptive in Long Cycles

Contraception

Netherlands, Canada, Germany
Bayer

Withdrawn

To Investigate Efficacy of YAZ in the Treatment of Dysmenorrhea

Dysmenorrhea
Bayer

Completed

YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China

Contraception

China
Bayer

Completed

YAZ Premenstrual Dysphoric Disorder (PMDD) in China

Premenstrual Dysphoric Disorder ( PMDD)

China
Bayer

Completed

Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ

Contraception | Ovulation Inhibition | Contraceptives, Oral

United States
Bayer

Withdrawn

Clinical Study of a Conventional and Flexible Extended Oral Contraceptive of EE/DRSP With or Without Metafolin in Latin America

Contraception
Bayer

Completed

Efficacy and Safety Oral Contraceptive Study

Contraception
Bayer

Completed

Evaluate Safety and Efficacy of an Oral Contraceptive (OC) Preparation Versus Placebo for 6 Treatment Cycles in Women With Moderate Acne

Acne Vulgaris

United States
Bayer

Completed

Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.

Acne Vulgaris

United States
Bayer

Completed

Yasmin Post Marketing Surveillance

Contraception

Korea, Republic of
Bayer

Completed

LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study

Contraception

Belgium, United States, Russian Federation, Germany, Austria
Bayer

Completed

Effects of Counseling on the Continuation Rates and Compliance for Newly Prescribed Oral Contraceptives (Yasmin® or Any Other Oral Contraceptives (OC)

Contraception

Saudi Arabia, Jordan, Lebanon, Bahrain, Kuwait, Oman, Qatar, Hungary, Albania, Egypt, Kenya, Macedonia, The Former Yugoslav Republic of, United Arab Emirates
Bayer

Completed

Comparative Study of BAY86-5300 With an Extended Flexible Regimen for Endometriosis

Endometriosis

Japan
Bayer

Completed

Comparative Trial in Hormone Withdrawal Associated Symptoms

Oral Contraceptive

Switzerland, Portugal, Chile, Italy, Korea, Republic of, Venezuela, Philippines, Colombia, Thailand, Argentina, Germany, Russian Federation, United Kingdom, Czech Republic
Bayer

Completed

Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: YAZ and YAZ + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) and YAZ + Levomefolate Calcium (Metafolin)

Contraception

Netherlands
Bayer

Completed

Effects of Drospirenone-containing or -Not Containing Combined Oral Contraceptives on General and Sexual Well-being (COSME)

Contraception

Italy
Bayer

Completed

GA YAZ ACNE in China Phase III

Acne Vulgaris

China
Bayer

Completed

Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception

Contraception

Mexico
Bayer

Completed

Study to Investigate the Effect of Missed Pills on Follicular Development in Two Application Regimens of SH T 00186 D

Contraceptives, Oral

Netherlands
Bayer

Completed

Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function

Contraception

France, Italy, Spain, Germany, United Kingdom
Bayer

Completed

Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: Yasmin and Yasmin + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafolin) and Yasmin + Levomefolate Calcium (Metafolin)

Contraception

Germany
Bayer
University of California, San Francisco; Laboratorium für Klinische Forschung; Diagnostic Cytology Laboratory

Completed

Endometrial Safety Study

Postmenopause

Mexico, United States, Italy, Denmark, Austria, Argentina, Brazil, Russian Federation
Bayer

Completed

YAZ, Oral Contraceptive Registration in China

Contraception

China, Hong Kong
University of Manitoba
Riverview Health Centre Foundation

Completed

Treating Foot Drop in People With Multiple Sclerosis Using Electrical Stimulation

Multiple Sclerosis | Foot Drop

Canada
Bayer

Completed

Low-dose Hormone Therapy for Relief of Vasomotor Symptoms

Vasomotor Symptoms | Hot Flashes

United States
Bayer

Completed

Efficacy and Safety Study of ZK219477 in Patients With Recurrent Ovarian Cancer

Ovarian Neoplasms
Bayer

Completed

Angeliq Regulatory Post Marketing Surveillance (Angeliq rPMS)

Osteoporosis, Postmenopausal | Postmenopausal Period

Korea, Republic of
Bayer

Terminated

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer

Small Cell Lung Carcinoma
Bioness Inc
University of Cincinnati; Medidata Solutions

Completed

Clinical Study of the L300 Versus Ankle-foot Orthosis (AFO) on Post-Stroke Subjects With Foot Drop (L300)

Gait, Drop Foot | Sensorimotor Gait Disorder | Neurologic Ambulation Disorder | Poststroke Hemiparesis | Post-Cerebrovascular Accident (CVA) Hemiparesis

United States
Bayer

Completed

Efficacy and Tolerability of Angeliq in Thai Women

Postmenopause
Bayer

Completed

Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.

Vasomotor Symptoms

China
Bayer

Completed

A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer

Carcinoma, Small Cell

Germany
Bayer

Completed

Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer

Breast Neoplasm

United States, Canada
Bayer

Completed

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer

Breast Neoplasms | Breast Cancer, Metastatic

France, Germany, Spain, Austria, Belgium, Slovenia, Poland, Bulgaria, United Kingdom, Italy
Bayer

Completed

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer

Carcinoma, Non Small Cell Lung

Germany
Alcon Research

Completed

Acute Comfort and Blur Profile of a Lubricant Eye Drop Versus a Marketed Eye Ointment

Dry Eye
Bayer

Completed

Bleeding Pattern Study

Oral Contraceptive

Germany
Bayer

Completed

BAY81-8781, I.V. Aspirin in the Indication of Acute Coronary Syndrome (ACS) (ACUTE)

Acute Coronary Syndrome

Spain, China, Germany, Russian Federation
Children's Hospital of Philadelphia
National Institutes of Health (NIH); National Center for Complementary and...

Completed

Vitamin D Dose Finding Study

HIV Infections | AIDS

United States
Prof. Dr. Jörg Leuppi

Completed

High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study (VitCov)

Covid19 | Vitamin D Deficiency | Corona Virus Infection | ARDS | SARS-CoV Infection | Coronavirus

Switzerland

3

Subscribe